|
N
|
195
|
83
| |
|
Age (years)
|
42 (32, 51)
|
42 (29, 51)
|
0.79
|
|
Diabetes duration (years)
|
20 (11, 30)
|
18 (9, 29)
|
0.58
|
|
Sex
|
|
Women
|
89 (46)
|
30 (36)
|
0.15 b
|
|
Men
|
106 (54)
|
53 (64)
|
|
Depression
|
27 (14)
|
2 (2)
|
0.003 b
|
|
High galectin-3 (≥2.6 ng/ml) c
|
27 (14)
|
14 (17)
|
0.58 b
|
|
High HbA1c (> 70 mmol/mol (> 8.6%))
|
53 (27)
|
22 (26)
|
> 0.99 b
|
|
Total cholesterol (mmol/l)
|
4.6 (4.1, 5.2)
|
4.5 (4.0, 5.0)
|
0.13
|
|
LDL (mmol/l)
|
2.9 (2.4, 3.4)
|
2.8 (2.4, 3.2)
|
0.34
|
|
Triglycerides (mmol/l)
|
0.9 (0.7, 1.3)
|
0.8 (0.7, 1.2)
|
0.19
|
|
HDL (mmol/l)
|
1.5 (1.3, 1.8)
|
1.6 (1.3, 1.8)
|
0.71
|
|
Triglycerides/HDL-cholesterol ratio
|
0.6 (0.4–0.9)
|
0.6 (0.4–0.8)
|
0.23
|
|
S-Creatinine (μmol/l) d
|
70 (62, 77)
|
70 (62, 80)
|
0.44
|
|
Abdominal obesity e
|
33 (17)
|
11 (13)
|
0.48 b
|
|
BMI (kg/m2) f
|
24.6 (22.4, 27.9)
|
24.6 (23.1, 26.1)
|
0.92
|
|
Systolic BP (mm Hg)
|
120 (110, 130)
|
120 (110, 130)
|
0.34
|
|
Diastolic BP (mm Hg)
|
70 (70, 75)
|
70 (65, 78)
|
0.54
|
|
Hypoglycemia (severe episodes)
|
7 (4)
|
4 (5)
|
0.74 b
|
|
Smoking g
|
20 (11)
|
8 (10)
|
> 0.99 b
|
|
Physical inactivity h
|
24 (13)
|
5 (6)
|
0.19 b
|
|
Continuous subcutaneous insulin infusion
|
11 (6)
|
14 (17)
|
0.005 b
|
|
Antidepressants
|
16 (8)
|
6 (7)
|
> 0.99 b
|
|
Lipid lowering drugs
|
92 (47)
|
36 (43)
|
0.60 b
|
|
Antihypertensive drugs
|
62 (32)
|
26 (31)
|
> 0.99 b
|
|
Cardiovascular complications
|
8 (4)
|
2 (2)
|
0.73 b
|
